
The study explores the effects of Magnolol on human preadipocytes. Findings show that Magnolol enhances preadipocyte proliferation, differentiation, and adipokine secretion, particularly adiponectin. Increased expression of adipogenic markers and lipid accumulation were observed, suggesting its potential for restoring healthy adipose tissue. These results indicate that Magnolol could be used in topical formulations to combat age-related fat atrophy and improve skin health.
Like
Save
Share